In the Neo-adjuvant Treatment of Gastro-esophageal Cancers
Pre- and peri-operative strategies are becoming standard for the management of Localized gastro-esophageal cancer. For localized gastric/gastro-esophageal junction (GEJ) cancer there are conflicting data that a peri-operative approach with cisplatin-based chemotherapy improves survival, with the benefits seen in esophageal cancer likely less than a 5—10% incremental improvement. Further trends toward improvement in local control and [...]

